Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01424085 · ClinicalTrials.gov registry record
Antibiotic Prophylaxis Before Percutaneous Gastrostomy
A clinical trial of Infection, sponsored by University of Washington.
- Completed
- Registry status
- 124
- Enrollment target
- 1
- Study location
NCT01424085 is a study of Infection that has completed, run by University of Washington. The registered enrollment target is 124 participants, below the 723-participant average among 41 other Infection trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01424085, a study of Infection, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 124 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the use of antibiotics (i.e. Kefzol) before percutaneous gastrostomy performed in interventional radiology. Patient will be randomized to receive antibiotics or placebo before the procedure, and the rates of skin infection after the procedure will be determined between the two groups. This has never been studied in our population of patients undergoing the procedure. However, antibiotics are routinely given despite the lack of evidence. The investigators hypothesize that patient receiving prophylactic antibiotics will have a decreased number of infections compared to placebo.
Conditions Studied
Study Locations (1)
Washington
- Harborview Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2012-05 |
| Est. Completion | 2016-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01424085
The ClinicalTrials.gov registry entry for NCT01424085 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 723-participant average among 41 other Infection trials with a reported enrollment target (83% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Infection appearing as the primary indexed condition, and to 0 interventions.
NCT01424085 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT01424085 about?
NCT01424085 is a clinical study titled "Antibiotic Prophylaxis Before Percutaneous Gastrostomy". The purpose of this study is to evaluate the use of antibiotics (i.e. Kefzol) before percutaneous gastrostomy performed in interventional radiology. Patient will be randomized to receive antibiotics or placebo before the procedure, and the rates of skin infection after the procedure will be determin...
What is the current status of trial NCT01424085?
This trial is currently completed. The enrollment target is 124 participants. The study started on 2012-05. Estimated completion is 2016-02.
What conditions does trial NCT01424085 study?
This clinical trial studies the following conditions: Infection.
Who is sponsoring clinical trial NCT01424085?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01424085 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Copper Supplementation in Cirrhosis
RECRUITING · NA
-
Persona Revision Knee System Outcomes
RECRUITING
-
NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)
RECRUITING · Phase 1
-
Diagnosis and Management of Inflammatory and Infectious Diseases
RECRUITING
-
BLOOM: Pragmatic Feasibility Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.